Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Blair Jobe

Dr. Blair Jobe

Surgical Oncology

Dr. Blair Jobe at Allegheny Health Network in Pittsburgh is known as a prolific medical researcher and one of the country’s preeminent specialists in esophageal disease.

Get in touch
Jump to a Topic:

About Blair Jobe

Accolades
  • Team Leader icon

    Team Leader

  • Minimally Invasive Surgery icon

    Minimally Invasive Surgery

Get to Know Dr. Blair Jobe

Dr. Blair Jobe is director of the Allegheny Health Network Esophageal and Lung Institute in Pittsburgh and a pioneer in the field of minimally invasive surgery.

Jobe is one of the country’s preeminent specialists in endoscopic therapy for the treatment of esophageal cancer. He also handles cases of malignant pleural mesothelioma.

As a prolific medical researcher, he has been the principal investigator for two large grants from the National Institutes of Health that focused on early detection of esophageal disease. The research includes the development of tissue and serum biomarkers.

Earlier in his career he was honored with a Health Care Heroes Award for his discovery of four protein biomarkers that later became an accurate and inexpensive way to determine whether esophageal cancer was present.

Specialties of Dr. Blair Jobe

  • Esophageal cancer
  • Esophageal motility disorders
  • Dysplasia
  • Barrett’s esophagus
  • Achalasia
  • Tracheal disorders

Dr. Blair Jobe’s Experience and Medical Education

  • Allegheny Health Network
  • University of Pittsburgh Medical Center
  • American Board of Surgery
  • Swedish Medical Center, Seattle (Fellowship)
  • Oregon Health & Science University (Residency)
  • Creighton University School of Medicine (M.D.)

Awards and Other Recognitions

  • Health Care Heroes Award, Pittsburgh Business Times
  • Outstanding Researcher of the Year Award, Society of American Gastrointestinal and Endoscopic Surgeons

Publications of Dr. Blair Jobe

  • Babar, L. et al. (2019, July 16). Prognostic immune markers for recurrence and survival in locally advanced esophageal adenocarcinoma. Oncotarget.
  • Kelly, R.J. et al. (2018, December 26). The Dynamic and Transient Immune Microenvironment in Locally Advanced Esophageal Adenocarcinoma Post Chemoradiation. Annals of Thoracic Surgery.
  • Komatsu, Y., Newhams, K.M. & Jobe, B.A. (2018, November 28). Enhancing the Detection of Barrett Esophagus. Thoracic Surgery Clinic.
  • Alicuben, E.T. et al. (2018, April 17). Worldwide Experience with Erosion of the Magnetic Sphincter Augmentation Device. Journal of Gastrointestinal Surgery.

Disclaimer: Dr. Blair Jobe has no professional affiliation with Asbestos.com.

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer.

Asbestos.com Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Fran Mannino, editor for The Mesothelioma Center
Edited by

2 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at Asbestos.com include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. Allegheny Health Network. (n.d.). Blair A. Jobe, MD.
    Retrieved from: https://doctors.ahn.org/blair-a-jobe
  2. ClinicalTrials.gov (2018, January 25). Evaluation of Balloon-based Cryoablation of Human Esophageal Epithelium. Retrieved from: https://www.clinicaltrials.gov/ct2/show/NCT01293448
  •  
  •  
  •  

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified July 28, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now